454 related articles for article (PubMed ID: 15235804)
1. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
2. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
Minaki H; Sasaki K; Honda H; Iwaki T
Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
[TBL] [Abstract][Full Text] [Related]
3. Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies.
Sasaki K; Doh-ura K; Ironside JW; Iwaki T
Acta Neuropathol; 2002 Mar; 103(3):199-208. PubMed ID: 11907798
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex.
Rodríguez A; Freixes M; Dalfó E; Martín M; Puig B; Ferrer I
Neuroscience; 2005; 131(4):825-32. PubMed ID: 15749337
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
[TBL] [Abstract][Full Text] [Related]
8. Molecular typing of PrPres in human sporadic CJD brain tissue.
Lewis V; Klug GM; Hill AF; Collins SJ
Methods Mol Biol; 2008; 459():241-7. PubMed ID: 18576159
[TBL] [Abstract][Full Text] [Related]
9. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
[TBL] [Abstract][Full Text] [Related]
10. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
12. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
Ferrer I; Puig B; Blanco R; Martí E
Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
[TBL] [Abstract][Full Text] [Related]
13. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
14. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
[TBL] [Abstract][Full Text] [Related]
15. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
Ritchie DL; Head MW; Ironside JW
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
[TBL] [Abstract][Full Text] [Related]
16. Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients.
Kobayashi A; Arima K; Ogawa M; Murata M; Fukuda T; Kitamoto T
Acta Neuropathol; 2008 Nov; 116(5):561-6. PubMed ID: 18751990
[TBL] [Abstract][Full Text] [Related]
17. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease.
Schulz-Schaeffer WJ; Giese A; Windl O; Kretzschmar HA
Clin Neuropathol; 1996; 15(6):353-7. PubMed ID: 8937783
[TBL] [Abstract][Full Text] [Related]
19. Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
Kuczius T; Koch R; Keyvani K; Karch H; Grassi J; Groschup MH
Eur J Neurosci; 2007 May; 25(9):2649-55. PubMed ID: 17466020
[TBL] [Abstract][Full Text] [Related]
20. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]